Skip to main content
. Author manuscript; available in PMC: 2020 Jul 28.
Published in final edited form as: J Control Release. 2019 Jun 4;306:165–176. doi: 10.1016/j.jconrel.2019.06.003

Figure 7.

Figure 7.

R848-Toco recruits immune cells to tumors. Immune cell markers, CD8a, CD11d, and CD11c, are increased in AT84 tumors after 6 treatments of intratumoral Res-Toco/HA-Toco (25 μg on R848 basis). Representative images are shown from 3 independent experiments using an Olympus IX-81 inverted epifluorescence microscope. The entire tumor section is viewed as a montage of 10x magnification images. Scale bar is 2.5 mm.